Common Pain Reliever Linked to Cancer
Millions of people use over-the-counter pain relievers known as analgesics and nonsteroidal anti-inflammatory drugs (NSAIDs) every day. A new study shows that using a certain one of these medicines on a regular basis carries risks.
New Drug Therapy Shows Promise in Treating Leukemia
Acute lymphoblastic leukemia is the most common type of childhood cancer. A new drug therapy holds promise in treating this particularly aggressive disease.
Preventing Children's Cancers From Returning
Acute lymphoblastic leukemia (ALL) used to be one of the deadliest cancers for children and young adults. Now it's one of the most curable, and cures rates are climbing.
Understanding of Alzheimer's Expanding
If we only knew exactly what caused Alzheimer's disease, it might be easier to treat. Scientists are making headway in both arenas.
New Hope for Multiple Myeloma Patients
While there is no cure for multiple myeloma, a form of blood cancer, new therapy offers hope for keeping the disease from progressing. When used as a maintenance or ongoing therapy, Revlimid (lenalidomide) delays the progression of multiple myeloma and improves overall survival of newly diagnosed patients who have had a stem-cell transplant.
Closing in on the Leukemia Cure
The majority of patients with chronic myeloid leukemia recover using various cancer drug treatments. However, they are not cured, as a type of cancerous stem cell is resistant to the drugs.
"Turned Off" in Human Tumors
Researchers have gained new insights into one of the most aggressive tumors affecting humans, Burkitt's lymphoma cancer. There may be new ways of treating this painful and deadly disease with a new mechanism responsible for breaking down the genetic protections against tumors.
Un-Zombified Leukemia Cells
A team of University of Wisconsin-Madison researchers has successfully completed the first reprogramming of blood cells obtained from a patient with leukemia.
Certain Vaccines May Help Guard Against Childhood Cancer
Children vaccinated against hepatitis B might be at a lower risk of developing leukemia, according to a new study.
Follow-up Therapy Shown to Improve Lymphoma Survival Rates
Follicular lymphoma patients fare better after receiving two years of rituximab-maintenance therapy following immunochemotherapy, according to a new study.